The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMedium•23 February 2026•

1 min read

Gossamer Bio Investigated for Securities Fraud Following 75% Stock Price Collapse

Fortified uniQure building, fences, caution tape, security cameras. FDA buildings, US flags, justice symbols. Charts on tablets and papers.

Key Facts

1Law firm Block & Leviton is investigating Gossamer Bio, Inc. (Nasdaq: GOSS) for potential securities fraud.

Law firm Block & Leviton has launched a formal investigation into Gossamer Bio, Inc. (Nasdaq: GOSS) regarding potential securities fraud. The probe follows a catastrophic decline in the company's share price, which recently plummeted by more than 75%. Investigators are currently examining whether the biotechnology firm or its executives provided misleading information to the public and investors. This significant loss in market value has raised serious concerns among shareholders and regulatory watchdogs regarding the company's transparency. Investors who suffered substantial financial losses are being encouraged to participate in the investigation to determine if legal violations occurred. These developments place immense downward pressure on the firm's valuation and overall market reputation.